We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 9, 2018

Giugno v. Bristol-Myers Squibb Company et al

Track this case

Case Number:



California Northern

Nature of Suit:


Multi Party Litigation:

Class Action


Vince Chhabria


Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. February 12, 2018

    Bristol-Myers Oversold Lung Cancer Drug, Investors Say

    Bristol-Myers Squibb Co. was slapped with a putative class action in California federal court on Friday, alleging company officials deceived investors about the prospects for its lung cancer drug, which resulted in artificially inflated company stock prices that plunged when the therapy failed its clinical trial.


To view the parties, register now.